Clinical Diagnostics News and Research

RSS
Bio-Techne to acquire 100% ownership of Cliniqa

Bio-Techne to acquire 100% ownership of Cliniqa

Turkey steadily emerges as one of hottest healthcare markets in the world

Turkey steadily emerges as one of hottest healthcare markets in the world

Max Planck Institute researchers find protein profiles of DNA repair

Max Planck Institute researchers find protein profiles of DNA repair

PAML signs collaborative agreement with Axela

PAML signs collaborative agreement with Axela

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

A beginner’s guide to CRISPR genome editing

A beginner’s guide to CRISPR genome editing

Quest Diagnostics grants Supplier Excellence Awards to five companies

Quest Diagnostics grants Supplier Excellence Awards to five companies

IDT supports unique bioengineering public outreach program

IDT supports unique bioengineering public outreach program

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

Neurological testing accessibility and affordability: an interview with Dr Joseph Higgins

Neurological testing accessibility and affordability: an interview with Dr Joseph Higgins

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Researchers test new nanopore DNA sequencing technology to detect cause of antibiotic resistance

Researchers test new nanopore DNA sequencing technology to detect cause of antibiotic resistance

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.